Zhejiang Hisun Pharmaceutical Co., Ltd. (600267) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Zhejiang Hisun Pharmaceutical Co., Ltd.

Why is Zhejiang Hisun Pharmaceutical Co., Ltd. ?

With ROE of 5.96%, it has a attractive valuation with a 1.47 Price to Book Value

Over the past year, while the stock has generated a return of 17.56%, its profits have risen by 631.2% ; the PEG ratio of the company is 0
At the current price, the company has a high dividend yield of 2.1

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Zhejiang Hisun Pharmaceutical Co., Ltd. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Zhejiang Hisun Pharmaceutical Co., Ltd. for you?

Medium Risk, High Return

Absolute

Risk Adjusted

Volatility

Zhejiang Hisun Pharmaceutical Co., Ltd.

9.35%

1.15

28.95%

China Shanghai Composite

20.18%

1.58

14.20%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-2.87%

EBIT Growth (5y)

-1.79%

EBIT to Interest (avg)

2.76

Debt to EBITDA (avg)

3.34

Net Debt to Equity (avg)

0.35

Sales to Capital Employed (avg)

0.78

Tax Ratio

21.59%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

5.18%

ROE (avg)

6.61%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.17

EV to EBIT

11.29

EV to EBITDA

6.43

EV to Capital Employed

1.16

EV to Sales

1.05

PEG Ratio

0.44

Dividend Yield

ROCE (Latest)

10.26%

ROE (Latest)

8.20%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Bullish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Dow Theory

No Trend

Mildly Bearish

OBV

Mildly Bullish

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

22What is working for the Company

OPERATING CASH FLOW(Y)

Highest at CNY 2,231.34 MM

ROCE(HY)

Highest at 8.03%

DEBT-EQUITY RATIO (HY)

Lowest at 5.5 %

RAW MATERIAL COST(Y)

Fallen by -31.62% (YoY

INVENTORY TURNOVER RATIO(HY)

Highest at 3.72 times

DEBTORS TURNOVER RATIO(HY)

Highest at 6.35 times

PRE-TAX PROFIT(Q)

Highest at CNY 472.35 MM

NET PROFIT(Q)

Highest at CNY 355.97 MM

EPS(Q)

Highest at CNY 0.31

-5What is not working for the Company

OPERATING PROFIT MARGIN(Q)

Lowest at 12.63 %

NET SALES(Q)

Lowest at CNY 2,390.47 MM

OPERATING PROFIT(Q)

Lowest at CNY 301.93 MM

Here's what is working for Zhejiang Hisun Pharmaceutical Co., Ltd.

Operating Cash Flow

Highest at CNY 2,231.34 MM and Grown

In each year in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Pre-Tax Profit

At CNY 472.35 MM has Grown at 115.6%

over average net sales of the previous four periods of CNY 219.08 MM

MOJO Watch

Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (CNY MM)

Net Profit

At CNY 355.97 MM has Grown at 151.21%

over average net sales of the previous four periods of CNY 141.7 MM

MOJO Watch

Near term Net Profit trend is very positive

Net Profit (CNY MM)

Debt-Equity Ratio

Lowest at 5.5 % and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Pre-Tax Profit

Highest at CNY 472.35 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Net Profit

Highest at CNY 355.97 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CNY MM)

EPS

Highest at CNY 0.31

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (CNY)

Inventory Turnover Ratio

Highest at 3.72 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its inventory faster

Inventory Turnover Ratio

Debtors Turnover Ratio

Highest at 6.35 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost

Fallen by -31.62% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Zhejiang Hisun Pharmaceutical Co., Ltd.

Operating Profit Margin

Lowest at 12.63 % and Fallen

In each period in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales

Net Sales

Lowest at CNY 2,390.47 MM

in the last five periods

MOJO Watch

Near term sales trend is negative

Net Sales (CNY MM)

Net Sales

At CNY 2,390.47 MM has Fallen at -9.36%

over average net sales of the previous four periods of CNY 2,637.41 MM

MOJO Watch

Near term sales trend is negative

Net Sales (CNY MM)

Operating Profit

Lowest at CNY 301.93 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (CNY MM)